Online ISSN: 2149-3189
2015
Monthly
Nicaea Medical Publishing
Türkiye

Rivaroxaban-induced acute pancreatitis

Özgür Sirkeci, Emel Erkuş Sirkeci, Belma Taşel
DOI
https://doi.org/10.18621/eurj.417972
Abstract
Rivaroxaban is a direct factor Xa inhibitor and has been safely used since 2008. It is used for the detection of atrial fibrillation and venous thromboembolism. Pancreatitis is one of the rare but dangerous side effects of rivaroxaban. The case of a 53-year-old female patient that developed in the third month of drug usage was evaluated, and it was confirmed after a full analysis was conducted that excluded all other factors, such as biliary calculus, alcohol usage, hypertriglyceridemia, biochemical parameters, ultrasonography and computed tomography that the patient’s condition was caused by the use of Rivaroxaban. The aim of this case presentation is to indicate that awareness should be increased regarding the risks of using the drug Rivaroxaban, as it could lead to drug-induced pancreatitis, even though this is rare. 
Keywords
drug-induced pancreatitis, rivaroxaban, drug safety
References

[1] Cappell MS. Acute pancreatitis: etiology, clinical presentation, diagnosis, and therapy. Med Clin North Am 2008;92:889-923.

[2] Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis:an evidence-based review. Clin Gastroenterol Hepatol 2007;5:648-61.

[3] http://www.ehealthme.com/ds/xarelto/pancreatitis/

[4] Tenner S. Drug induced acute pancreatitis: Does it exist? World J Gastroenterol 2014;20:16529-34.

[5] Hung WY, Abreu Lanfranco O. Contemporary review of drug-induced pancreatitis: A different perspective. World J Gastrointest Pathophysiol 2014;5:405-15.

How to Cite
1.
Sirkeci Özgür, Erkuş Sirkeci E, Taşel B. Rivaroxaban-induced acute pancreatitis. Eur Res J. 2019;5(3):569-571. doi:10.18621/eurj.417972
License
Creative Commons License

Copyright (c) 2019 The European Research Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

View Vol. 5 No. 3 (2019)

Vol. 5 No. 3 (2019)

Article Information

  • Article Type Case Report
  • Submitted February 21, 2026
  • Published May 3, 2019
  • Issue Vol. 5 No. 3 (2019)
  • Section Case Report
  • File Downloads 7193
  • Abstract Views 323
  • Altmetrics
  • Share
Download data is not yet available.